HIV Malignancy Specimens for Research at No Charge
New off the press by the ACSR’s Dr. Jeffrey Bethony and colleagues from George Washington University, Scripps Research, the Fred Hutchinson Cancer Center, the National Institutes of Health and other …
From Cancer Moonshot Scholars program, originally published by the National Cancer Institute “The Cancer Moonshot Scholars program is designed to advance cancer science while also diversifying the pool of researchers …
(From the CFAR Adelante RFA: https://cfar-adelante.org/wp-content/uploads/2022/08/Adelante.RFA-CohortV_FINAL-081522.pdf) As confirmed by the National Ending the HIV Epidemic in the U.S. (EHE) Initiative, there has been adearth of culturally responsive research specific to …
A specific opportunity is available to work on projects related to Burkitt lymphoma (BL) in the context of research on the Epidemiology of Burkitt Lymphoma (BL) in East African Children …
The 18th International Conference on Malignancies in HIV/AIDS (ICMH) previously named the International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) will will be a held as a …
The Sexual & Gender Minority Research Office (SGMRO) is pleased to announce the publication of a Request for Information (RFI) on Research Opportunities and Operational Activities Related to the NIH Strategic Plan …
Please join the Office of AIDS Research (OAR) for the NIH World AIDS Day Observance Tuesday, December 1, 2020, from 11:00 a.m. to 12:30 p.m. EST. This virtual event is …
FOA Number: RFA-CA-20-046 Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to advance …
Funding Opportunity Announcement (FOA) Number PAR-20-106 The purpose of this Funding Opportunity Announcement (FOA) PAR-20-106 is to invite applications for the Centers for AIDS Research (CFAR) program-to provide administrative and …
POZ “Viral Control” Q & A with Dr. Robert Yarchoan, Director of the Office of HIV and AIDS Malignancy at the U.S. National Cancer Institute. (READ MORE)